Net selling: insiders sold $1.2B and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Lone Pine
$302.4M
added
Sells/Trims (2)
Durable Capital
$219.7M
trimmed
Point72
$147.0M
sold
Sells (3)
Gic Private Ltd
$274.8M
sold
Gic Private Ltd
$721.6M
sold
Gic Private Ltd
$57.3M
sold
Top-trader positions in MDLN could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Financial period
Q2 2026
Adjusted EPS
Company release
Revenue
$7.51B expected
Company GAAP EPS $0.07
EPS comparison unavailable.
Estimates as of Oct 24, 2026
EPS expected
$0.28 to $0.47
Revenue expected
23 analysts
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $0.50 | - | $7.68B $7.51B expected | +2.32% beat |
| Mar 31, 2026 | May 6, 2026 | $0.33 / $0.29Alpha Vantage | +13.79% beat | $7.35B No estimate | Unavailable |
| Dec 31, 2025 | Feb 25, 2026 | $0.38 / $0.24Alpha Vantage | +58.33% beat | $7.79B No estimate | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | Unavailable | - | $7.12B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.89B | $7.79B | $7.35B | $7.68B |
| Cost of what it sold | $5.16B | $5.87B | $5.69B | $5.47B |
| Gross profit | $1.73B | $1.91B | $1.67B | $2.21B |
| What it spent | ||||
| Sales and admin | — | $1.26B | $1.23B | $1.29B |
| Other operating costs | $1.10B | $224.0M | $15.0M | $525.0M |
| Total operating expenses | $1.10B | $1.49B | $1.24B | $1.82B |
| What was left | ||||
| Operating profit | $629.0M | $425.0M | $422.0M | $395.0M |
| Interest on debt | $233.0M | $166.0M | $165.0M | $168.0M |
| Profit before tax | $359.0M | $206.0M | $291.0M | $235.0M |
| Tax | $26.0M | $26.0M | $52.0M | $96.0M |
| Net profit | $333.0M | $180.0M | $129.0M | $60.0M |
| EBITDA | $842.0M | $467.0M | $681.0M | $659.0M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bearish
GIC Private Ltd and Affiliates Sell 7.8 Million Medline Shares at $35.15 Each
Leans bearishOct 13Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
BearishOct 13A 10% owner sells Medline (MDLN) shares; the reported indirect position afterward is 69.4M shares.
BearishOct 13Medline launches enhanced TrackPoint for real-time inventory and patient supply tracking in healthcare.
BullishOct 12Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
BearishOct 9